Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Y Feng

Showing results (71-80 of 459) with videos related to

Pageof 46
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 9, 2011
Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapyFelix Y Feng, Yushen Qian, Matthew H Stenmark, et al.
Current Urology Reports|June 8, 2017
Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate CancerRobert T Dess, Todd M Morgan, Paul L Nguyen, et al.
Plos One|May 15, 2015
Development and validation of a novel platform-independent metastasis signature in human breast cancerShuang G Zhao, Mark Shilkrut, Corey Speers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapseSchuyler Halverson, Matthew Schipper, Kevin Blas, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
Breast Cancer Research and Treatment|August 9, 2014
Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancerFelix Y Feng, Corey Speers, Meilan Liu, et al.
Oncogene|January 28, 2022
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
European Urology|January 23, 2022
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate CancerVanessa Di Lalla, Michael J Kucharczyk, Alexander W Wyatt, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structuresFelix Y Feng, Hyungjin M Kim, Teresa H Lyden, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablationAaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Pageof 46

Showing results (71-80 of 459) with videos related to

Sort By:
Pageof 46
International Journal of Radiation Oncology, Biology, Physics|August 9, 2011
Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapyFelix Y Feng, Yushen Qian, Matthew H Stenmark, et al.
Current Urology Reports|June 8, 2017
Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate CancerRobert T Dess, Todd M Morgan, Paul L Nguyen, et al.
Plos One|May 15, 2015
Development and validation of a novel platform-independent metastasis signature in human breast cancerShuang G Zhao, Mark Shilkrut, Corey Speers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapseSchuyler Halverson, Matthew Schipper, Kevin Blas, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
Breast Cancer Research and Treatment|August 9, 2014
Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancerFelix Y Feng, Corey Speers, Meilan Liu, et al.
Oncogene|January 28, 2022
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
European Urology|January 23, 2022
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate CancerVanessa Di Lalla, Michael J Kucharczyk, Alexander W Wyatt, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structuresFelix Y Feng, Hyungjin M Kim, Teresa H Lyden, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablationAaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Pageof 46